Astragaloside IV
Cat. No.：YN350228
CAS No. ：84687-43-4
| 产品名称: | Astragaloside IV |
| CAS No.: | 84687-43-4 |
| Chemical Name: | (3β,6α,16β,20R,24S)-20,24-epoxy-16,25-dihydroxy-3-(β-D-xylopyranosyloxy)-9,19-cyclolanostan-6-yl, β-D-glucopyranoside |
| Synonyms: | 黄芪甙 |
| 分子量: | 784.97 |
| 分子式: | C₄₁H₆₈O₁₄ |
| SMILES: | O[C@H]1[C@H](O)[C@@H](O)[C@]([H])(O[C@@H]2C(C)(C)[C@@]([C@@H](O[C@]3([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C[C@]4([H])[C@@]56CC[C@@]7(C)[C@@]4(C)C[C@H](O)[C@]7([H])[C@]8(C)O[C@H](C(C)(O)C)CC8)([H])[C@]5(C6)CC2)OC1 |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Astragaloside IV 是从黄芪中分到的皂苷类物质，能够抑制ERK1/2和JNK的激活，在乳腺癌细胞 MDA-MB-231 中，能够下调(MMP)-2，(MMP)-9的信号通路。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Ren, S., Zhang, H., Mu, Y., et al.Pharmacological effects of Astragaloside IV: A literature reviewJ. Tradit. Chin. Med.33(3),413-416(2013)
Shang, L., Qu, Z., Sun, L., et al.Astragaloside IV inhibits adenovirus replication and apoptosis in A549 cells in vitroJ. Pharm. Pharmacol.63(5),688-694(2011)
Li, L., Hou, X., Xu, R., et al.Research review on the pharmacological effects of astragaloside IVFundam. Clin. Pharmacol.31(1),17-36(2017)
Zhang, W.-D., Chen, H., Zhang, C., et al.Astragaloside IV from Astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitroPlanta Med.72(1),4-8(2006)
